i3 Acquires ChinaGate, Providing Customers with Greater, More Efficient Access to Chinese Market i3, a global life sciences services company and subsidiary of Ingenix, has acquired ChinaGate, a contract research organisation (CRO) that provides product-development regulatory services for pharmaceutical, medical device and biotechnology companies looking to enter and access the Chinese market.